IA
INSY

IFP Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

IFP Advisors’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1K Sell
200
-50
-20% -$237 ﹤0.01% 2309
2018
Q4 		$1K Sell
250
-100
-29% -$695 ﹤0.01% 3469
2018
Q3 		$4K Hold
350
– – ﹤0.01% 3361
2018
Q2 		$3K Buy
350
+200
+133% +$1.4K ﹤0.01% 3542
2018
Q1 		$1K Hold
150
– – ﹤0.01% 3722
2017
Q4 		$1K Sell
150
-780
-84% -$5.11K ﹤0.01% 3773
2017
Q3 		$8K Buy
930
+100
+12% +$1.03K ﹤0.01% 3192
2017
Q2 		$10K Sell
830
-920
-53% -$10.9K ﹤0.01% 3055
2017
Q1 		$18K Buy
1,750
+50
+3% +$533 ﹤0.01% 2585
2016
Q4 		$16K Buy
1,700
+100
+6% +$1.13K ﹤0.01% 2631
2016
Q3 		$19K Buy
1,600
+1,200
+300% +$18.2K ﹤0.01% 2455
2016
Q2 		$5K Buy
400
+200
+100% +$2.92K ﹤0.01% 3192
2016
Q1 		$1K Sell
200
-200
-50% -$3.8K ﹤0.01% 2290
2015
Q4 		$11K Buy
+400
New +$11.1K ﹤0.01% 2556

Other funds holding INSY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

IFP Advisors's INSY Position: Q1 2019 in Review

IFP Advisors reduced its Insys Therapeutics, Inc. (INSY) stake by 20% in Q1 2019, selling an estimated $237 and leaving 200 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2309.

IFP Advisors first reported a position in INSY in Q4 2015 and has held it in 14 quarters since. The position peaked at $19K in Q3 2016. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.

  • IFP Advisors held 200 shares of Insys Therapeutics, Inc. worth $1K as of Q1 2019.
  • IFP Advisors sold 50 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $237.
  • Insys Therapeutics, Inc. made up ﹤0.01% of IFP Advisors's portfolio in Q1 2019, its #2309 holding.
  • IFP Advisors first reported a position in Insys Therapeutics, Inc. in Q4 2015 and has held it in 14 quarters since.
  • IFP Advisors's Insys Therapeutics, Inc. position peaked at $19K in Q3 2016.
  • 98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.